AgroPages-Certis USA reaches global Licensing Agreement with the University of Szeged in Hungary for new microbial strain for biopesticides-Agricultural news

Certis USA announced that it entered into a global Licensing Agreement with the University of Szeged in Hungary for a novel, patented biopesticide strain, Bacillus mojavensis strain R3B. Certis USA will develop, manufacture and market the novel strain as a biopesticide product for agricultural and horticultural uses worldwide.

The patented strain has a unique profile and has been found to be an effective antagonist against many pathogens, in particular soil-borne diseases, that effect fruits and vegetables. The university has identified the strain as copper resistant, allowing it to be combined with copper pesticides for enhanced control of plant pathogens.

This agreement brings another innovative technology to Certis USA’s growing platform of biopesticides based on Bacillus technology, such as Bacillus thuringiensis, Bacillus amyloliquefaciens and Bacillus mycoides.

Subscribe Email:		*
Name:
Mobile Number:

A Deep exploration into Regulatory Analysis, Join upcoming <2024 CROs & CRAOs Manual>Magazine

Join 2024 Formulation & Adjuvant Technology Magazine to Show Your Insights and Innovation SolutionsMagazine

BioEx 2024 successfully held: Biological innovation leading the way towards sustainable agricultureEvent

Certis USA reaches global Licensing Agreement with the University of Szeged in Hungary for new microbial strain for biopesticides

Certis Biologicals
United States
Follow

More from AgroNewsChange

Magazine

Hot Topic More

NEWSLETTER